In his latest article for RealMoney.com, Validea CEO John Reese looks at some healthcare stocks that are getting high marks from his Guru Strategies.

“As a historically noncyclical industry, the prospects for healthcare have rarely been healthier,” Reese writes. “Demand tends to hold up even when the economy is sickly, because people need health services no matter what the economy does. Aging baby boomers are increasingly in need of healthcare services, and that will boost demand over the long term. Further, over time, the recent Supreme Court ruling upholding the Affordable Care Act will also likely increase Americans’ usage of healthcare.”

Reese notes that his Validea Pro Healthcare Portfolio is up about 20% this year — and says he thinks many of these stocks have further to run.  “It would not surprise me if investor fear over the Affordable Care Act has held down healthcare stocks, even as they have performed well this year,” he writes. “If I am correct, these still have ample room to move up in the coming months and years.” Reese looks at three healthcare plays that his strategies — each of which is based on the approach of a different investing great — have been high on recently. Among them: drug giant Pfizer. To read the full article, click here.